| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Director | Mar 01, 2023 | Buy | $22.73 | 2,500 | 56,816 | 10,000 | Mar 02, 2023, 04:27 PM | |
| VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Director | Jan 05, 2023 | Buy | $24.96 | 2,500 | 62,396 | 7,500 | Jan 09, 2023, 11:51 AM | |
| VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Director | Jan 04, 2023 | Buy | $25.25 | 2,500 | 63,136 | 5,000 | Jan 05, 2023, 05:00 PM | |
| VIR | Vir Biotechnology, Inc. | Sigal Charles Elliott | Director | Jan 03, 2023 | Buy | $25.60 | 2,500 | 63,993 | 2,500 | Jan 05, 2023, 05:00 PM | |
| ADAP | Adaptimmune Therapeutics PLC | Sigal Charles Elliott | Director | May 19, 2016 | Buy | $1.56 | 15,000 | 23,400 | 314,100 | May 19, 2016, 04:47 PM | |
| ADAP | Adaptimmune Therapeutics PLC | Sigal Charles Elliott | Director | May 16, 2016 | Buy | $1.50 | 15,000 | 22,500 | 269,100 | May 18, 2016, 07:34 PM | |
| ADAP | Adaptimmune Therapeutics PLC | Sigal Charles Elliott | Director | May 17, 2016 | Buy | $1.53 | 15,000 | 22,950 | 284,100 | May 18, 2016, 07:34 PM | |
| ADAP | Adaptimmune Therapeutics PLC | Sigal Charles Elliott | Director | May 18, 2016 | Buy | $1.55 | 15,000 | 23,250 | 299,100 | May 18, 2016, 07:34 PM |
Menu